Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Total Current Liabilities: 2019-2025

Historic Total Current Liabilities for Burning Rock Biotech (BNR) over the last 1 years, with Jun 2025 value amounting to $230.1 million.

  • Burning Rock Biotech's Total Current Liabilities was N/A to $230.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $230.1 million, marking a year-over-year change of. This contributed to the annual value of $36.5 million for FY2024, which is 1.65% down from last year.
  • Burning Rock Biotech's Total Current Liabilities amounted to $230.1 million in Q2 2025, which was up 530.77% from $36.5 million recorded in Q4 2024.
  • In the past 5 years, Burning Rock Biotech's Total Current Liabilities registered a high of $230.1 million during Q2 2025, and its lowest value of $36.5 million during Q4 2024.
  • Moreover, its 3-year median value for Total Current Liabilities was $37.1 million (2023), whereas its average is $101.2 million.
  • In the last 5 years, Burning Rock Biotech's Total Current Liabilities spiked by 57.78% in 2021 and then tumbled by 37.82% in 2023.
  • Burning Rock Biotech's Total Current Liabilities (Quarterly) stood at $58.4 million in 2021, then climbed by 2.14% to $59.7 million in 2022, then plummeted by 37.82% to $37.1 million in 2023, then decreased by 1.65% to $36.5 million in 2024, then reached $230.1 million in 2025.
  • Its Total Current Liabilities stands at $230.1 million for Q2 2025, versus $36.5 million for Q4 2024 and $37.1 million for Q4 2023.